Charis Gresser

Aug 11, 2023 | brunswickgroup.com | Charis Gresser |Tanisha Carino |Jennifer Sukawaty |Kate Larsen

Interview with incoming Director of the UK Dementia Research Institute Professor Siddharthan ChandranNew disease-modifying drugs that target sticky amyloid plaques in the brain have been hailed as a turning-point in treating Alzheimer’s. Yet important questions remain over access, identifying those patients who will benefit, developing improved healthcare infrastructure and monitoring potentially dangerous side effects.

Jul 5, 2023 | brunswickgroup.com | Charis Gresser |Jennifer Sukawaty

Kate LarsenAssociate, San Francisco I represented Brunswick’s San Francisco office at the two-day conference in Los Angeles, where it was made clear that nobody in the healthcare space is waiting for certainty to seek solutions for a healthier future. From AI-enabled stethoscopes and male birth control to the menopause market, innovation was in full swing.

Jun 21, 2023 | brunswickgroup.com | Charis Gresser

Any company in the world that is engaged in the use and collection of consumer health data should take note of the following key aspects of Washington’s My Health My Data Act (MHMDA):A regulated entity means any organization – including nonprofits – that has commercial ties to Washington and collects, processes, shares or sells consumer health data. Consumers aren’t defined as state residents, rather as anyone whose data is processed in Washington.